The Biotechnology Industry

The primary goal of the biotechnology industry is to invent new biologically-active substances, for the treatment of disease, the pharmaceutical industry, and the management of agriculture.

The U.S. is the world leader in biotechnology, currently providing employment for more than 300,000 people in over 6,000 U.S. biotech companies, with an estimated market capitalization of approximately USD 281 billion in 2008. The biotechnology industry has more than tripled in size since 2000, with revenues increasing from USD 25 billion in 2000 to more than USD 80 billion in 2008. In 2007, Amgen, Inc., the world's largest biotechnology company, achieved total sales of USD 14.7 billion. Expectations are that the biotechnology market will increase to more than USD 130 billion by 2011.

Biotechnology

Geographically, the U.S. accounts for 65% of the biotechnology market, Europe 23%, Canada 7%, Australia 3%, and the rest of the world, 2%.

The Biotechnology Industry

Today, genomics and bioinformatics development both are being pursued within major pharmaceutical companies. There have been key collaborations with traditional IT technology companies such as IBM, Hitachi, Ltd., Samsung, SK Telecomm and Motorola. The U.S. biotechnology research and pharmaceutical industry spent a record USD 8.5 billion in 2007 on the R&D of new medicines and vaccines. As of 2006, the biotechnology industry compared favorably with the pharmaceutical industry in terms of R&D expenditures per employee. Venture capital investments in bioscience companies reached USD 11.6 billion in 2007.

Ernst & Young reported that in 2006, 82 publicly-traded Canadian biotech firms claimed S3.2 billion in revenue, accounting for 4.4% of global biotech revenues. Human health accounts for the largest segment of the Canadian biotech industry, representing more than half the interest of all biotech companies, approximately 70% of all biotech revenues and nearly 90% of all biotech R&D. Bioinforrnatics provides an important capability for the Canadian biotech industry, encompassing genomics and other "omics", tissue engineering and drug discovery technology.

Canadian bioinformatics companies include Bioinformatics Solutions, Inc., DNA LandMarks, Inc., and Kinexus Bioinformatics Corporation. Montreal, Quebec, has Canada's leading biotech cluster, followed by Toronto, Ontario; Vancouver, British Columbia; and Winnipeg, Manitoba.

Five European Union (E.U.) member states-Denmark, Finland, Germany, Sweden and the U.K.-continue to be world leaders in biotech innovation along with the U.S. and Japan. In the second half' of 2007, European biotech companies reached USD 765.3 million in venture capital investment. In January and February of 2008, venture capital funds invested a total of USD 145.6 million into new European biotech companies; however, with the economic stresses of the latter part of the year, many European biotech firms may find it harder to raise money in early 2009.

The Biotechnology Industry Organization of Germany (BlO Deutschland), located in Berlin, has more than 180 members, including companies, BioRegions, and sector service providers. The goal of the organization is to support and promote a stable economy through innovation in bioscience. Among the German biotech companies are the Biotechnology Research and Information Network (BRAIN AG), 4SC. AG, Bionas, UmbEl and Direvo, which recently (September 2008) was purchased by the German pharmaceutical and chemicals giant Bayer HealthCare. In view of' the burgeoning German biotech sector, traditional German scientific companies like Eppendorf, AG, Sartorius, AG and Qiagen also have gotten into the act.

The Biotechnology IndustryHalo: Reach - Fails of the Weak Volume 29 (Funny Halo Bloopers and Screw-Ups!) Video Clips. Duration : 4.02 Mins.

Jack and Geoff are back looking at some of the funniest fails in the world of Halo: Reach. You know you love it!

Tags: Achievement, Hunter, Rooster, Teeth, Fails, of, the, Weak, Week, Volume, 29, Watch, out, for, that, killer, Moa!

Dr. Richard Graydon, http://www.medauthor.com, trained as an Oncologist, holding both M.D. and PhD degrees, specializing in molecular genetics and cancer research. His education and experience have provided him analytical and clinical skills for keen insight into diagnosis, treatment, and care of cancer patients. See http://www.medauthor.com for further information

New York City Readies for Biotech Industry

Being an international city, New York City is always abreast with developments in the different fields of science. In fact, it is home to some of the world's leading academic and scientific research institutions, medical institutions, pharmaceutical and commercial bioscience companies and parks. Among the many regions in the U.S., it also has the biggest bioscience workforce.

Bioscience technology or biotech for short refers to the research or study of living organisms and bioprocesses such as in technology, medicine and engineering among others. Today, its applications include the four major industries - health care, agriculture and crop production, non food uses of products and crops such as biodegradable plastic and biofuel and environment.

Biotechnology

In the U.S., the biotech industry has been experiencing rapid growth. The major players are companies involved in the research and creation of new medicines and vaccines using plant and animal genes. Medicines produced by these businesses have been found to be effective in treating serious health conditions that were not curable in the past such as cancer, Alzheimer's disease and multiple sclerosis among others. Currently, New York City is one of the major recipients of the National Institute of Health funds meant for medical research.

New York City Readies for Biotech Industry

The latest development is the construction of multi-million dollar bioscience complexes in the city specifically commercial laboratory space. Some of them can be found in the Lower Manhattan area while the others are in Sunset Park and near the Fifth Avenue. The aim is to attract more companies to set up shop in New York City in the coming years.

The downtown area particularly near the World Trade Center site is also considered to be ideal as a biotech center. This plan is expected to cost around million.

The head of the city's Economic Development Corporation, however, pointed out that commercial laboratory complexes near the academic medical institutions stand to benefit more due to the greater possibility of luring bioscience companies that they help generate every year. Target businesses include those engaged in the research of cancer and neurosciences, dental research and pharmaceutical firms.

These newly constructed laboratory buildings are said to provide a more comfortable atmosphere suitable for research work. With more space and lighting plus a great view, workers will be encouraged to perform their tasks better.

Officials of New York City are also determined to improve their area's biotech industry and lure more companies. In 2009, they even proposed to offer valuable tax breaks in the amount of million each year to attract biotech companies.

When businesses in the biotech industry start to put up offices in New York City, this will not only help pump up the city's revenues but will provide thousands of jobs as well. With the support of the city and state officials, the plan of making New York City as a biotech center in the future is not impossible to achieve. While success may not be gained right away, economic development experts believe the biotechnology sector is one area of growth that shows a lot of potential.

New York City Readies for Biotech IndustryMinecraft - "Shadow of Israphel" Part 9: The Abandoned Mine Video Clips. Duration : 12.17 Mins.

Simon and Lewis investigate a long-abandoned mineshaft and discover a terrible secret. Please like and favourite to support this series! Huge thanks to Blake Evans, for the utterly epic conclusion. Facebook: www.facebook.com Our Podcast: itunes.apple.com Texture pack is DSB's Gerudoku remix, around page 17 of this thread: www.minecraftforum.net

Tags: minecraft, adventure, mode, survival, multiplayer, yogscast, beta, israphel, notch, xephos, honeydew, lewis, simon, old peculier, daisy duke, skylord lysander, airship

For information on finding a chiropractor in NYC, visit AnselmiChiropractic.com.

A Glance at the Clinical Research Organization Industry

Clinical Research Organizations provide on going drug development services to the medical-device, biotechnology and pharmaceutical industries, where the industry sponsors are able to manage product-development processes that are far more efficient and cost effective.

The global Clinical Research Organization market size has been estimated at approximately £35 billion and continues to grow steadily. Revenue increases at an annual rate of 14 to 16%.

Biotechnology

Clinical trials conducted by the CROs are completed on an average of approximately thirty percent faster than those that are conducted in-house, according to an independent analyst. This means on average, four to five months in the year worth of time is saved, equating to roughly £240 million to £300 million in increased revenue potential.

A Glance at the Clinical Research Organization Industry

The CRO (research and pharmacology) industry is global. Leading companies are familiar with regulatory affairs and common business practices in many countries across the globe.

CROs employ roughly 100,000 clinical professionals across the globe. In addition to this, CROs hold high ethical standards and fully comply with Good Clinical Practice (GCP) and Good Laboratory Practices (GLP) that have been published by regulatory authorities. Clients are provided with a superior resource, clinical and non-clinical drug development experience, therapeutic and regulatory expertise and modern technology.

With a flexible approach, CROs offer a wide range of specialist services including clinical trial design, protocol writing, CRF design, regulatory applications, clinical data management, pharmacy, laboratory etc. The range of services offered means that they are able to offer single service components or full-scale clinical trial solutions.

A Glance at the Clinical Research Organization IndustryHalo: Reach - Achievement HORSE #3 Tube. Duration : 9.60 Mins.

Jack and Geoff (with the occasional Burnie) are back playing another round of HORSE in Halo: Reach. Things get crazy as they burn through a bunch of user-created maps in a race to become the best Halo HORSE player ever! If you'd like to try the maps used in this video, go to tinyurl.com

Keywords: Achievement, Hunter, Halo, Bungie, Microsoft, HORSE, Jack, Geoff, Burnie, Rooster, Teeth, User, Created, Maps

The author has extensive experience in the worldwide pharmaceutical industry (Institute of clinical research). Trained as a microbiologist with in the 1970s, she performed research and medical writing on the in vivo evaluation of novel penicillins and was extremely passionate about the development of Augmentin, the first penicillin-B-lactamase inhibitor combination.

Pharmaceutical Industry in India, Top Pharma Companies and Jobs

Image : http://www.flickr.com

Pharmaceutical companies in India are growing at a very fast pace and this has made the Indian pharmaceutical industry as the second largest growing industry. Also the pharmaceutical industry in India is the third largest in the world, which will be of US$20 billion by 2015. Mergers and acquisitions are the part of this growth. The compounded annual growth rate of pharma in India is 12-15% and the global figures are 4-7% for the period of 2008-2013. With such a profound growth of pharmaceutical companies in India numerous pharmaceutical jobs can be seen. This in turn is helping biotechnology industry and booming the biotechnology jobs in India.

Angel Broking has done a research on the growth of pharmaceutical industry and found that by 2015 the pharmaceutical industry in India will be in the top 10 markets. Yet another finding of FICCI-Ernst & Young study reveals that the population of high income group in India is rising which will give rise to more influx of MNCs and expensive drugs.

Pharmaceutical companies along with native companies are also competing with the top MNCs. Such a profound growth is because of the heavy population figures and with the increasing number of middle class people and their income the access to drugs and medicines is also increasing. But still the low-priced generics are popular in Indian pharmaceutical industry.

From India in year 2007-08 total of US$ 8.25 billion were exported and there was seen 29% rise in this figure in 2009. MR Anand Sharma, Union Minister of Commerce said that pharmaceutical sector in India has grown and it is the major contributor to exports from India. In 1990 the amount was meager as compare to today's massive figures.

Initiatives by Government

1. Tax breaks are offered to pharma industry


2. New procedure for the development drugs


3. Proper clinical procedures


4. New Millennium Indian Technology Leadership Initiative and the Drugs and Pharmaceuticals Research Programme - Two schemes launched by the government.

Some Vital Information on Pharmaceutical Companies in India

• In terms of volume - India's pharmaceutical industry is the third largest in the entire world.


• In terms of value - India's pharmaceutical industry ranks fourteenth


• By 2015 - It will be in the list of top 10 global pharmaceutical markets and it will touch US $ 20 billion.


• 2008-2009 - Saw 29% growth in exports of pharmaceutical drugs as compared to 2007


• 2013 - Indian formulation market is expected to touch US$ 13.7 billion

Top 10 Pharmaceutical Companies in India

• Ranbaxy


• Dr Reddy's Laboratories


• Cipla


• Sun Pharma Industries


• Lupin Labs


• Aurobindo Pharma


• GlaxoSmithKline Pharma


• Cadila Healthcare


• Aventis Pharma


• Ipca Laboratories

R Oberoi is associated with Manpower from India and recommends http://www.manpowerindia.net for searching and finding information on all kinds of jobs.